Literature DB >> 15253277

Sex influence on chronic intestinal inflammation in Helicobacter hepaticus-infected A/JCr mice.

Robert S Livingston1, Mathew H Myles, Beth A Livingston, Jennifer M Criley, Craig L Franklin.   

Abstract

Helicobacter hepaticus is a bacterial pathogen of mice that has been reported to cause chronic intestinal inflammation in A/JCr, germfree Swiss Webster, and immunodeficient mice. To the authors' knowledge, the influence of sex on development of chronic intestinal inflammation in H. hepaticus-infected mice has not been investigated. The purposes of the study reported here were to determine whether severity of intestinal inflammation differs between male and female A/JCr mice chronically infected with H. hepaticus and to characterize the mucosal immune response in these mice. The cecum of male and female A/JCr mice infected with H. hepaticus for 1 month and 3 months was objectively evaluated histologically for intestinal disease. Also, semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) analysis was done to measure interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha), interleukin 4 (IL-4), IL-10, macrophage inflammatory protein-1alpha (MIP-1alpha), interferon-inducible protein of 10 kDa (IP-10), and monokine induced by gamma interferon (MIG) mRNA values in the cecal tissue of these mice. Significant differences in cecal lesion scores were not present at 1 month after infection. However, infected female mice had significantly up-regulated expression of cecal IL-10, MIP-1alpha, IP-10, and MIG mRNA compared with that in uninfected females, and expression of IL-10 and MIP-1alpha was significantly greater than that detected in infected male mice (P < or = 0.05). At 3 months after infection, cecal lesion scores were significantly (P < or = 0.05) increased in female and male mice compared with uninfected controls, and infected female mice had significantly (P < or = 0.05) higher cecal lesion scores than did infected male mice. In addition, infected females had significant (P < or = 0.05) increases in cecal IFN-gamma, TNF-alpha, IL-10, MIP-1alpha, IP-10, and MIG mRNA values compared with values in uninfected females and infected males, and male mice had significant (P < or = 0.05) increases in cecal TNF-alpha and IL-10 mRNA values compared with those for male control mice. These data indicate that, in H. hepaticus-infected A/JCr mice, females develop more severe intestinal inflammation than do males, and the chronic mucosal inflammation is polarized toward a Th1 response that is not down-regulated by increased activity of IL-10. We propose that H. hepaticus-infected A/JCr mice will serve as a good animal model with which to study the influence of sex on bacterial-induced mucosal inflammation.

Entities:  

Mesh:

Year:  2004        PMID: 15253277

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  15 in total

1.  Lurking in the shadows: emerging rodent infectious diseases.

Authors:  David G Besselsen; Craig L Franklin; Robert S Livingston; Lela K Riley
Journal:  ILAR J       Date:  2008

2.  Quantitative trait loci in a bacterially induced model of inflammatory bowel disease.

Authors:  Andrew E Hillhouse; Matthew H Myles; Jeremy F Taylor; Elizabeth C Bryda; Craig L Franklin
Journal:  Mamm Genome       Date:  2011-06-30       Impact factor: 2.957

3.  Fast disease progression in simian HIV-infected female macaque is accompanied by a robust local inflammatory innate immune and microbial response.

Authors:  Wuze Ren; Yingfei Ma; Liying Yang; Agegnehu Gettie; January Salas; Kasi Russell; James Blanchard; Amy Davidow; Zhiheng Pei; Theresa L Chang; Cecilia Cheng-Mayer
Journal:  AIDS       Date:  2015-06-19       Impact factor: 4.177

4.  Probiotic Lactobacillus spp. diminish Helicobacter hepaticus-induced inflammatory bowel disease in interleukin-10-deficient mice.

Authors:  Jeremy A Peña; Arlin B Rogers; Zhongming Ge; Vivian Ng; Sandra Y Li; James G Fox; James Versalovic
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

5.  Cytolethal distending toxin is essential for Helicobacter hepaticus colonization in outbred Swiss Webster mice.

Authors:  Zhongming Ge; Yan Feng; Mark T Whary; Prashant R Nambiar; Shilu Xu; Vivian Ng; Nancy S Taylor; James G Fox
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

6.  Gut Microbial Dysbiosis Due to Helicobacter Drives an Increase in Marginal Zone B Cells in the Absence of IL-10 Signaling in Macrophages.

Authors:  Avijit Ray; Sreemanti Basu; Raad Z Gharaibeh; Lydia C Cook; Ranjit Kumar; Elliot J Lefkowitz; Catherine R Walker; Casey D Morrow; Craig L Franklin; Terrence L Geiger; Nita H Salzman; Anthony Fodor; Bonnie N Dittel
Journal:  J Immunol       Date:  2015-08-31       Impact factor: 5.422

7.  Colitis-induced bone loss is gender dependent and associated with increased inflammation.

Authors:  Regina Irwin; Taehyung Lee; Vincent B Young; Narayanan Parameswaran; Laura R McCabe
Journal:  Inflamm Bowel Dis       Date:  2013-07       Impact factor: 5.325

8.  Novel Helicobacter species H.japonicum isolated from laboratory mice from Japan induces typhlocolitis and lower bowel carcinoma in C57BL/129 IL10-/- mice.

Authors:  Zeli Shen; Yan Feng; Sureshkumar Muthupalani; Alexander Sheh; Lenzie E Cheaney; Christian A Kaufman; Guanyu Gong; Bruce J Paster; James G Fox
Journal:  Carcinogenesis       Date:  2016-09-21       Impact factor: 4.944

9.  Helicobacter hepaticus HHGI1 is a pathogenicity island associated with typhlocolitis in B6.129-IL10 tm1Cgn mice.

Authors:  Zhongming Ge; Torsten Sterzenbach; Mark T Whary; Barry H Rickman; Arlin B Rogers; Zeli Shen; Nancy S Taylor; David B Schauer; Christine Josenhans; Sebastian Suerbaum; James G Fox
Journal:  Microbes Infect       Date:  2008-04-04       Impact factor: 2.700

10.  Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens.

Authors:  J G Fox; Y Feng; E J Theve; A R Raczynski; J L A Fiala; A L Doernte; M Williams; J L McFaline; J M Essigmann; D B Schauer; S R Tannenbaum; P C Dedon; S A Weinman; S M Lemon; R C Fry; A B Rogers
Journal:  Gut       Date:  2010-01       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.